Launched in 2014, Viridian Capital Advisors was one of the first and now leading, corporate finance, M&A, advisory and research practices in the legal Cannabis/CBD industries, and now in the Psychedelics sector. We represent companies, investors, lenders, buyers and sellers. Our advisory practice is meant to help “institutionalize” our clients before they go to market for capital or M&A - by helping to build a professional Board of Directors, sophisticated financial models, valuation analyses, and exit strategies. Our investment banking practice raises capital and executes M&A transactions through our New York City based broker-dealer, Bradley Woods & Co. Ltd.

Viridian is widely recognized as the industry leader in research and capital markets data/market intelligence through the Viridian Deal Tracker. Launched in January 2015, and having analyzed more than $60 billion in deals, the Viridian Deal Tracker is a proprietary data service that monitors and analyzes investment, M&A activity and capital markets trends in the Cannabis/CBD and Psychedelics industries. The Deal Tracker has become a trusted and valuable source for companies, investors, lenders and sellers/acquirers to make informed capital allocation decisions.

‍We surrounded ourselves with an Advisory Board comprised of former President’s, CEO’s and C-Suite executives from some of the largest companies in the CPG, Big Brand and Private Equity industries, including Diageo, Proctor & Gamble, Anheuser Busch, Mars Wrigley, Dixie Brands, Pantheon Partners and Conde Nast. Leveraging our team’s decades of high level operating and transactional experience we provide comprehensive strategic and financial solutions that assist cannabis enterprises in realizing their full potential

Data Driven

Industry Trusted

Results Oriented

Experienced